abiraterone acetate
abiraterone acetate is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including abiraterone acetate, YONSA, Abiraterone Acetate. Available dosage forms: tablet, tablet, film coated.
Drug details
- Generic Name
- abiraterone acetate
- Brand Names
- abiraterone acetate, YONSA, Abiraterone Acetate, ABIRATERONE ACETATE, Zytiga
- Application Number
- ANDA209227
- Sponsor
- Glenmark Pharmaceuticals Inc., USA
- NDC Codes
- 17
- Dosage Forms
- TABLET, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ABIRATERONE ACETATE
Indications and Usage
1 INDICATIONS AND USAGE Abiraterone acetate tablets are indicated in combination with prednisone for the treatment of patients with Metastatic castration-resistant prostate cancer (CRPC) Metastatic high-risk castration-sensitive prostate cancer (CSPC) Abiraterone acetate tablets are a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). ( 1 ) metastatic high-risk castration-sensitive prostate cancer (CSPC). ( 1 )